Porcine circovirus type 2 (PCV2) is the primary aetiological agent of porcine circovirusassociated disease in swine. The mechanism of PCV2 pathogenesis remains largely unknown. A newly identified viral protein of PCV2, ORF4, has been suggested to be involved in virus-induced apoptosis. However, there is still no information regarding the molecular mechanism by which ORF4 regulates apoptosis. In this study, we reveal that a physical interaction between the PCV2 ORF4 protein and ferritin heavy chain (FHC) in the cytoplasm of host cells reduced the cellular concentration of FHC. The ORF4-mediated reduction of FHC inhibited reactive oxygen species accumulation in PCV2-infected cells. Consequently, the ORF4 protein inhibited apoptosis in host cells. This may be the first report to describe the mechanism of ORF4 cytoprotection against apoptosis during the early stages of PCV2 infection.
INTRODUCTION
Porcine circovirus type 2 (PCV2), a pathogenic strain of porcine circovirus (PCV), has been identified as the primary aetiological agent of porcine circovirus-associated disease (PCVAD), which causes immense economic losses in swine production worldwide (Clark, 1997; Segal es et al., 2005; Gillespie et al., 2009; Ge et al., 2012) . Its miniscule, single-stranded circular DNA genome is approximately 1.76 kb and carries only two major ORFs: ORF1 encodes two replicase proteins (Rep and Rep¢), which are indispensable for viral replication (Mankertz & Hillenbrand, 2001; Cheung, 2003; Mankertz et al., 2003) , and ORF2 encodes the capsid protein (Cap), which is the major structural protein and the dominant immunogenic antigen of PCV2 (Nawagitgul et al., 2002) . Several smaller ORFs have also been found, but only expression of ORF3 and ORF4 has been characterized in detail. ORF3 encodes an apoptotic protein that is dispensable for viral infection but is involved in the virulence and spread of the virus (Liu et al., 2005; Karuppannan et al., 2009; Juhan et al., 2010; Karuppannan & Kwang, 2011) . The ORF4 protein is not essential for viral replication, but it appears to be involved in inhibiting apoptosis Gao et al., 2014) . In addition, a novel ORF5 protein has recently been identified in PCV2-infected cells and may also affect PCV2 infection (Lv et al., 2015a) .
As the smallest DNA virus, with a highly limited coding capacity, PCV2 growth relies extensively on host cell factors (Meng, 2013) . Thus, PCV2 must explore diverse strategies to subvert cellular factors or processes to facilitate its replication. Among these is the modulation of host immune function, which results in cytokine imbalance, immunosuppression and disease (Meng, 2013) . However, the virushost interactions encompass much more than this. PCV2 has also employed the host autophagic machinery to effectively enhance its own replication (Zhu et al., 2012a) . In addition, the induction of apoptosis has been proposed as a natural part of the viral life cycle (Roulston et al., 1999) and may be a powerful strategy that PCV2 has adopted for the release and dissemination of host cell-produced progeny virions (Liu et al., 2005) . Obviously, completion of these biological processes is achieved through interactions between PCV2 and its cellular partners. For example, the Cap protein has been shown to activate AMPK and is therefore responsible for PCV2-triggered autophagy (Zhu et al., 2012b) , and the ORF3 protein an competitively bind pPirh2 with p53 to play a major role in PCV2-induced apoptosis (Liu et al., 2007) . During the last decade, scholars have searched for a trigger molecule responsible for PCV2-induced diseases and have successively identified several porcine proteins that interact with the viral Rep/Rep¢ (ORF1), Cap (ORF2), ORF3 and ORF4 proteins via a †These authors contributed equally to this work.
yeast-or bacteria-based two-hybrid assay (Timmusk et al., 2006; Liu et al., 2007; Finsterbusch et al., 2009; Lv et al., 2015b) , although the details of these interactions remain unknown at this time. To date, however, the molecular basis of PCV2 pathogenesis remains elusive, and there are still no data on the molecular mechanism of the ORF4 protein regulating apoptosis.
With regard to apoptosis, PCV2 or its ORF3 protein reportedly induced apoptosis in cultured PK15 cells, mouse splenic macrophages and porcine peripheral blood mononuclear cells (PBMCS), and this process appeared to be dependent on caspase-3 and caspase-8 activity but not on caspase-9 activity (Kiupel et al., 2001; Liu et al., 2005; Lin et al., 2011) . Indeed, PCV2-induced B-lymphocyte depletion has also been ascribed to apoptosis (Shibahara et al., 2000) , although contradictory evidence suggests decreased cell proliferation rather than apoptosis as the reason for this hallmark of PCV2 infection (Mandrioli et al., 2004) . Interestingly, the newly characterized ORF4 protein was found to play a role in suppressing caspase activity and modulating the host immune system via regulation of CD4 + and CD8 + T lymphocytes during PCV2 infection . Hence, PCV2 may prevent apoptosis by expressing its own anti-apoptotic gene to complete its propagation in the early stage of PCV2 infection, but in the late stage, it promotes apoptosis either to kill uninfected immune cells or to induce the breakdown of infected cells in the host and, thereby, facilitate viral dissemination. If so, it is necessary to further clarify whether and how the ORF4 protein is involved in the anti-apoptotic mechanism, as all the functions of ORF4 described above are based on indirect results.
In this study, we demonstrated that the PCV2 ORF4 protein has an anti-apoptotic function by stabilizing the concentration of the ferritin heavy chain (FHC) through physical interaction. These results will contribute to elucidating the molecular mechanisms of early infection by PCV2.
RESULTS

ORF4
Per se is not anti-apoptotic but antagonizes PCV2-induced apoptosis Previously, the anti-apoptotic activity of PCV2 ORF4 was assessed using an ORF4-deficient PCV2 mutant clone . To directly confirm this result, PK15 stable cell lines expressing either GFP-ORF4 fusion proteins or GFP alone were constructed and subjected to flow cytometry analysis. As shown in Fig. 1(a) , expression of GFP and the GFP-ORF4 fusion proteins was visible under an inverted fluorescence microscope (Nikon), but no green fluorescence was detected in the mock-transfected PK15 cells. Immunoblotting using an anti-GFP antibody indicated that PK15 cells transfected with pEGFP-ORF4 and the pEGFP-C1 plasmid expressed proteins of approximately 33 kDa and 27 kDa, respectively (Fig. 1b) . However, no immunoreactive band was visualized in the negative control cells. These results confirmed the expression of the PCV2 ORF4 protein in PK15 cells. The results of flow cytometry indicated that the ORF4 protein alone did not have an apoptosis-promoting effect, but its anti-apoptotic effect was also low, suggesting that the anti-apoptotic role of ORF4 is achieved through the process of PCV2 infection. To clarify this issue, various PK15 cell lines were infected with the PCV2 virus. As shown in Fig. 1(e, f) , apoptotic activity induced by PCV2 in PK15 cells was significantly higher than that produced by PCV2 in ORF4-expressing cells. However, the level of apoptosis detected in PCV2-infected ORF4-expressing cells was still higher than that produced in the mock-infected cells. These results indicate that the ORF4 protein is able to partially antagonize PCV2-induced apoptosis.
ORF4 has no impact on the pro-apoptotic function of ORF3
It has been reported that the ORF3 protein is critical for PCV2-triggered apoptosis (Liu et al., 2005) . To further clarify whether the ORF4-triggered anti-apoptotic effect relies on the inhibition of ORF3-induced pro-apoptotic functions, PK15 cells were infected with recombinant lentiviruses expressing intact ORF3 and subjected to flow cytometry analysis at 72 h after infection. As shown in Fig. 2(c, d) , apoptosis induced by overexpression of ORF3 in ORF4-expressing cells was similar to that in control cells. Subsequent real-time quantitative RT-PCR analysis demonstrated that there was no significant difference in the levels of ORF3 mRNA among lentivirusinfected PK15 cells (Fig. 2e) . These data suggest that the ORF4 protein is probably not involved in ORF3-induced apoptosis, although a recently published study contradicts these results as two ORF4-deficient PCV2 viruses showed significantly higher ORF3 transcription levels than WT PCV2 virus (Gao et al., 2014) .
FHC interacts with ORF4 in the cytoplasm of PK15 cells
Evidence for the interaction between ORF4 and FHC has recently been demonstrated as described above (Lv et al., 2015b) . However, it is still unclear whether the endogenous FHC binds the ORF4 protein within host cells, especially in PK15 cells. To clarify this issue, we performed immunofluorescence assays with the relevant antibodies using confocal microscopy and co-immunoprecipitation (co-IP) assays with anti-FHC antibodies and Western blotting with anti-DsRed. Co-localization of ORF4 and FHC in the cytoplasm of PK15 cells was clearly visible as shown in Fig. 3(a) , and endogenous FHC precipitated DsRed-ORF4 but not DsRed alone, which is shown in Fig. 3b , indicating that endogenous FHC interacts with the PCV2 ORF4 protein in the cytoplasm of host cells. FHC is involved in PCV2-induced apoptosis FHC, the primary iron storage factor, acts as an effective anti-apoptotic molecule that protects cells from apoptosis induced by a variety of pro-apoptotic stimuli (Brouard et al., 2000; Berberat et al., 2003) . However, the effect of FHC on PCV2-triggered apoptosis is unknown. To clarify this issue, we investigated the impact of FHC expression on apoptosis in PCV2-infected cells using flow cytometry. As shown in Fig. 4 , lentivirus-mediated overexpression of FHC significantly reduced the number of apoptotic cells in PCV2- 
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Relative levels of ORF3 mRNA expression infected cells, compared with untreated cells. Conversely, knockdown of FHC by short hairpin RNA (shRNA) (Fig. 4c, d ) markedly increased the number of apoptotic cells (Fig. 4e, f) . Taken together, these results support the hypothesis that FHC is involved in PCV2-induced apoptosis.
ORF4 stabilizes the concentration of FHC in PCV2-infected cells
Recently, the anti-apoptotic effect of FHC was reported to be dose-dependent as shown by the induction of toxicity at doses higher than the protective range and the limited effect at lower doses (Berberat et al., 2003) . Therefore, we hypothesized that the interaction between ORF4 and host FHC may be important in the regulation of FHC expression. To confirm this hypothesis, FHC mRNA in PCV2-infected PK15 cells and mock-infected cells was first measured by real-time quantitative RT-PCR at the time points indicated, and mRNA expression curves were plotted. As shown in Fig. 5(a) , the FHC transcription levels in PCV2-infected PK15 cells were significantly higher than those in mockinfected cells (P<0.05), which indicated that PCV2 infection of PK15 cells activates the transcription of FHC. These data are consistent with previous results showing that FHC is induced downstream of NF-kB (Pham et al., 2004) , because PCV2 infection strongly induces the activation of NF-kB (Wei et al., 2008) . Additionally, the FHC mRNA levels in PCV2-infected PK15 cells, ORF4-deficient PCV2-infected PK15 cells and PCV2-infected ORF4-expressing PK15 cells at 72 h post-infection were also measured by real-time quantitative RT-PCR. As shown in Fig. 5(b) , similar levels of FHC mRNA were identified in all three groups, which suggested that the interaction between ORF4 and FHC may not influence FHC transcription. Finally, cell lysates from the above-mentioned experimental groups were subjected to Western blot analyses. As shown in Fig. 6 , the protein level of FHC in PCV2-infected ORF4-expressing PK15 cells was significantly lower than that in mock-infected cells (P<0.001), the protein level of FHC in ORF4-deficient PCV2-infected PK15 cells was significantly higher than that in mock-infected cells (P<0.001), and the protein level of FHC in PCV2-infected PK15 cells was also significantly lower than that in ORF4-deficient PCV2-infected PK15 cells (P<0.01), indicating that the ORF4 protein can reduce the FHC protein levels in host cells. Notably, the facilitated reduction of the FHC protein band in PCV2-infected and PCV2-infected ORF4-expressing PK15 cells was attributed to the gradual increase in another immunoreactive band, which was located over the FHC protein band (Fig. 6a ). These observations suggest that facilitated reduction of the FHC by ORF4 is likely achieved through protein modification. The combined results indicate that a direct interaction between ORF4 and host FHC may control the FHC protein levels in virus-infected cells. Considering the important role of FHC in apoptosis, these results suggest that the PCV2 ORF4 protein antagonizes apoptosis by stabilizing the concentration of FHC in PCV2-infected cells.
ORF4 suppresses reactive oxygen species (ROS) accumulation in PCV2-infected cells
ROS can mediate cell death triggered by a variety of stimuli, including TNFa, ceramide, radiation and chemotherapeutic agents (Pham et al., 2004) . Recently, a time-dependent increase in ROS during PCV2 infection has been reported (Chen et al., 2012) , and this progression was shown to alter NF-kB activity (Chen et al., 2012) . Activation of the NF-kB pathway promotes the expression of pro-inflammatory molecules, such as TNFa, E-selectin, P-selectin, ICAM-1 and VCAM-1 (Berberat et al., 2003) , and is thus a crucial component of the cellular defence against PCV2 infection . Interestingly, FHC is induced downstream of NFkB and is identified as an essential mediator of TNFa-triggered apoptosis via control of ROS induction (Pham et al., 2004) . Given the above results, we speculated that the interaction between ORF4 and host FHC may influence ROS accumulation during PCV2 infection. To investigate this hypothesis, the production of ROS was measured 72 h after the infection of PCV2 or PCV2D in PK15 cells. As shown in Fig. 7 , the mean OD 650 values in PK15 cells infected with PCV2 or PCV2D at 72 h were significantly higher than those in the mock cells, which further confirmed that PCV2 infection induces ROS production in PK15 cells. Compared with the PCV2-infected cells, the PCV2D-infected cells produced much more ROS, resulting in a considerably higher OD 650 value, while the PCV2-infected ORF4-expressing cells produced lower ROS levels, leading to a significantly lower OD 650 value. These data indicate that ORF4 is associated with the control of ROS, and, therefore, we reasoned that PCV2 inhibits ROS accumulation through the interaction of FHC and ORF4.
DISCUSSION
PCV2 infection has been shown to induce apoptosis in cells (Kiupel et al., 2001; Liu et al., 2005) , and the major mechanism underlying PCV2-mediated apoptosis has also been clarified (Liu et al., 2007) . However, PCV2 must antagonize apoptosis to replicate prior to cell death due to its extensive dependence on the host cell machinery. The ORF4 protein of PCV2 has been proposed as an anti-apoptotic protein Gao et al., 2014) and even a molecule down-regulating host cell signalling (Choi et al., 2015) ; therefore, defining how ORF4 antagonizes apoptosis during the early stages of PCV2 infection may explain how PCV2 manipulates apoptosis to facilitate its replication.
Currently, several porcine proteins have been identified as binding partners of the ORF4 protein using a yeast mating approach (Lv et al., 2015b) . Among these, FHC has been shown to bind exogenous ORF4 in transfected cells. FHC can act as an anti-apoptotic protein that protects cultured cells from apoptosis induced by a variety of stimuli (Berberat et al., 2003) and is therefore the most likely molecule to be involved in inhibition of apoptosis triggered by PCV2 ORF4. In particular, a previously published study reported that FHC is induced downstream of NF-kB and inhibits TNFainduced apoptosis by suppressing ROS (Pham et al., 2004) . As activation of the NF-kB signalling pathway and production of ROS were reportedly detected in PCV2-infected PK15 cells (Wei et al., 2008; Chen et al., 2012) , the interaction between ORF4 and host FHC may be responsible for inhibition of apoptosis by PCV2 during its early infection.
To confirm this possibility, we first demonstrated that the ORF4 protein itself is not anti-apoptotic but antagonizes PCV2-induced apoptosis (Fig. 1) , and that ORF4 has no impact on the pro-apoptotic function of ORF3 (Fig. 2) . Interestingly, a recent report suggested that the PCV2 ORF4 protein may prevent virus-induced apoptosis by restricting ORF3 transcription (Gao et al., 2014) . Therefore, the data reported here are inconsistent with previous results. However, our hypothesis is a possibility, as the previous results are derived from an indirect presumed method. We then focused on the interaction between ORF4 and host FHC and demonstrated that ORF4 physically interacted with endogenous FHC in the cytoplasm (Fig. 3) . This observation provides further evidence supporting the idea that ORF4-mediated inhibition of apoptosis is achieved through its physical interaction with host FHC. To confirm this hypothesis, we explored the role of FHC in PCV2 infection. The results indicated that FHC is involved in PCV2-induced apoptosis, as shown by the reduced apoptosis in FHC-overexpressing cells and the increased apoptosis in FHC knockdown cells (Fig. 4) . Given previous reports that the anti-apoptotic effect of FHC was dose-dependent (Berberat et al., 2003) , we determined whether the PCV2 ORF4 protein affects the cellular concentration of FHC during PCV2 infection. The results clearly indicated that expression of ORF4 leads to a significant reduction in FHC protein but no change in FHC mRNA (Figs 5 and 6) . Notably, there was a larger immunoreactive band in addition to the FHC band (Fig. 6a) , suggesting that stabilization of FHC at low concentrations of ORF4 may be associated with modification of the FHC protein through their physical interaction. These results were further confirmed by analyses of ROS production in various PK15 cells infected with PCV2 or PCV2D (Fig. 7) .
In summary, the mechanism by which the PCV2 ORF4 protein antagonizes apoptosis in PCV2-infected cells was defined in this study. The ORF4 protein physically binds host FHC, resulting in the reduction of FHC protein levels in host cells. Reduction of FHC concentration further inhibits the accumulation of ROS in host cells, leading to reduced apoptosis. This report may be the first explanation of the mechanism by which ORF4 protein confers cytoprotection against apoptosis during the early stages of PCV2 infection.
METHODS
Vectors, viruses and cells. The pEGFP-C1 eukaryotic expression vector was purchased from Clontech (USA). The pcDNA3.1(+) eukaryotic expression vector was purchased from Invitrogen. The eukaryotic expression plasmid pDsRed-ORF4 was maintained in our laboratory (Lv et al., 2015b) . The PCV2 virus used in this study was originally isolated from a pig with naturally occurring postweaning multisystemic wasting syndrome in the Guanzhong region of China (Tang et al., 2011) . PCV-free PK15 cells, which were kindly provided by Qing-hai Tang, Nanyang Normal University, PR China, were cultured in highglucose Dulbecco's modified Eagle's medium (DMEM) (Gibco) supplemented with 10 % FBS (Gibco) at 37 C in a 5 % CO 2 incubator (Tang et al., 2013) . HEK293T cells were cultured as described previously (Zhang et al., 2015) .
Antibodies and reagents. A mouse anti-GFP polyclonal antibody was purchased from Sungene Biotech. A mouse anti-GAPDH monoclonal antibody and a horseradish peroxidase (HRP)-conjugated goat antimouse IgG antibody were purchased from Sigma-Aldrich. Rabbit anti-FHC antisera and HRP-conjugated goat anti-rabbit antiserum were purchased from Abcam. A rabbit anti-DsRed polyclonal antibody was purchased from Clontech. A goat anti-rabbit IgG H&L (Alexa Fluor-488) was purchased from Abcam. Hoechst 33342 was purchased from Beyotime. ROS levels in each sample were evaluated using the cell superoxide anion in situ assay. OD 650 values are shown as the mean±SD from three independent experiments. **P<0.01 versus the control group.
TCAGGGACAACGGAGTG-3¢). After purification, the amplified product was cloned into the pEGFP-C1 eukaryotic expression vector. After confirmation by enzymic digestion and DNA sequencing, the recombinant plasmid was named pEGFP-ORF4. PK15 cells grown in 12-well dishes were transfected with pEGFP-ORF4 and a pEGFP-C1 control vector using TurboFect (Thermo). After incubation at 37 C for 48 h, cultures were propagated in selection media containing 1000 µg G418 ml À1 for 2 weeks. When all control cells showed evidence of death in the presence of the selection agents, cultures transfected with pEGFP-ORF4 were propagated for two further weeks in selection media containing 500 µg G418 ml
À1
. After confirmation by immunoblotting, the resultant PK15 cell lines stably expressing either GFP-ORF4 or GFP alone were used for the follow-up studies.
Cell apoptosis detection by flow cytometry. To determine the impact of ORF4 protein expression on apoptosis in the established cell lines, annexin V-PE and propidium iodide (PI) staining and flow cytometry were performed. Briefly, cells grown in six-well culture dishes were treated with trypsin, washed three times with PBS and resuspended to a concentration of 0.5-1.0Â10 6 cells ml
. After the addition of 0.2 µg of PE-tagged annexin-V and 100 µl binding buffer, cells were incubated at 25 C in the dark for 30 min. After washing with PBS, 0.25 µg PI and 400 µl binding buffer were added sequentially. Finally, apoptotic cells were examined by a Coulter Epics XL FACS (Beckman).
Lentivector construction and lentivirus production. Recombinant lentiviruses expressing intact ORF3 and FHC were constructed as previously described with slight modifications (Zhang et al., 2015) . Briefly, the cDNA for the PCV2 ORF3 and porcine FHC proteins were cloned into the over-expression lentivector pCDH-CMV-MCS-EF1-GreenPuro (CD513B-1) (SBI) to generate the LV-ORF3 and LV-FHC plasmids using the primer pairs ORF3-F (5¢-CGGAATTCATGGTAACCATCC-CACCACTTG-3¢)/ORF3-R (5¢-C GGGATCCTTACTTATCGTCGT-CATCCTTGTAATCCTGATAGAATGTGGAGC-3¢) and FHC-F (5¢-CCGGAATTCATGACGACCTCGTGCTCCTCG-3¢)/FHC-R (5¢-CGG-GATCCTTAGCTCTCACTGCTCCCCAGGGTG-3¢) (underlined characters show the restriction sites and italics indicate the Flag tag), respectively. The four pairs of short hairpin RNA (shRNA) targeting porcine FHC and a negative control shRNA listed in Table 1 were cloned into the knockdown lentivector pCDH-U6-MCS-EF1-GreenPuro (SBI) to generate the FHC-sh1, FHC-sh2, FHC-sh3, FHC-sh4 and FHC-shN plasmids. HEK293T cells (up to 70-80 % confluence) were co-transfected with the constructs in combination with pGag/Pol, pRev and pVSVG utilizing TurboFect (Thermo) according to the manufacturer's guide. After 16 h, the medium was replaced with advanced DMEM (Gibco) containing 2 % FBS, 0.01 mmol yolk lecithin l À1 , 0.01 mmol cholesterol l À1 and 1Â Chemically Defined Lipid Concentrate (Invitrogen, USA) and incubated for another 48 h. Subsequently, culture supernatant was collected to infect PK15 cells as follows. PK15 cells were seeded in a 12-well plate and incubated for 24 h. After the removal of 50 % of the medium, polybrene was added to each well to a final concentration of 6 µg ml
, and lentiviruses were added at an m.o.i. of 1. After incubation at 37 C overnight, the medium was replaced with fresh medium. After another 72 h, fluorescence microscopy and Western blotting were used to evaluate the expression of ORF3 and FHC.
Immunoblotting analysis. Western blot analysis was performed as described elsewhere with some modifications . Briefly, protein samples were separated by SDS-PAGE and transferred onto PVDF membranes (Millipore). After blocking with 5 % skimmed milk, the membranes were probed with the primary antibodies indicated at room temperature for 2 h, followed by incubation with HRP-conjugated secondary antibodies. Finally, immunoreactive bands were visualized by chemiluminescence using an enhanced ECL Western blotting analysis system (Thermo). The cellular protein GAPDH served as an internal control.
Real-time quantitative RT-PCR. Real-time quantitative RT-PCR was performed to measure the relative quantification of gene expression as described previously (Lv et al., 2015a) . Briefly, total RNA was isolated from PK15 cell samples using TRIzol (Invitrogen) and was used as a template for reverse transcription with a PrimeScript RT reagent kit (TaKaRa). Gene expression was quantified via a Bio-Rad iQ5 Multicolor Real-Time PCR Detection System using SYBR Premix Ex Taq II (TaKaRa) according to the manufacturer's recommendations. The realtime quantitative RT-PCR assays were performed with the primer pairs F-ORF3 (5¢-CTTCCAATCACGCTTCTG-3¢)/R-ORF3 (5¢-GACAACG-GAGTGACCTG-3¢), F-FHC (5¢-CCGCGATG ATGTGGCTTTG-3¢)/ R-FHC (5¢-GGTTTCATGATATCCTGAAGG-3¢) and F-b-actin (5¢-GGACCTCTACGCCAACAC-3¢)/R-b-actin (5¢-GGAGGCGCGAT-GATCTT-3¢). Finally, the relative expression level of genes was analysed using the 2
ÀDDCt method with porcine b-actin as an internal control (Livak & Schmittgen, 2001 ).
Confocal microscopy and co-IP assays. To determine whether the ORF4 protein interacts with endogenous FHC, confocal microscopy was performed as previously described with slight modifications (Lv et al., 2015b) . To further confirm this result, PK15 cells grown in six-well plates were transfected with pDsRed-ORF4. As a negative control, the empty pDsRed-Monomer-C1-transfected cells were used. At 48 h posttransfection, the cells were washed twice with PBS and treated with lysis buffer (containing PMSF) for 30 min on ice. After centrifugation, the supernatants were subjected to immunoprecipitation using rabbit anti-FHC antiserum for 2 h at 4 C. After the addition of 30 µl of protein G Sepharose (GE healthcare) at 4 C for 2 h, the immuno complex was Construction of the ORF4-deficient PCV2 mutant clone. Recombinant plasmid pSK-W containing the complete genome of PCV2 was constructed by our lab (Lv et al., 2015a) . To generate the infectious PCV2 mutant clones, a specific mutation altering the start codon of ORF4 from ATG to ACG was introduced into the cloned PCV2 genome with a set of mutagenic primers, F(5¢-AAGACTAATGTACACGTCGT-TAGTCTTCCAATC-3¢) and R(5¢-GATTGGAAGACTAACGACGTG-TACATTAGTCTT-3¢) (mutant site is underlined), according to the protocol of a site-directed gene mutagenesis kit (Beyotime). After excision from the pSK-W plasmid and re-circularization by ligation, the resultant DNA mixture was transfected into PCV-free PK15 cells using TurboFect (Thermo). After incubation at 37 C for 24 h, fresh medium containing 300 mM D-glucosamine was added. After 48 h, three successive freeze-thaw cycles were performed on the genome-transfected PK15 cells to harvest viral stocks.
Assay of intracellular ROS. ROS levels were measured with a cell superoxide anion in situ assay kit (Genmed). Nitro blue tetrazolium (NBT) from this kit is reduced by ROS to blue formazan, which was then measured at 650 nm with a microplate reader (Multiskan FC, Thermo). PK15 cells were seeded in 96-well plates at a density of 5 Â10 3 per well, infected with PCV2 or PCV2D at an m.o.i. of 1 at 4 h postseeding and incubated at 37 C for 72 h. PK15 cells pre-incubated with 50 µM arachidonic acid (Sigma) for 30 min and mock-infected PK15 cells were used as controls. After addition of 20 µl NBT and incubation at 37 C for 4 h, 100 µl of fixative solution was added to cultures, followed by 100 µl of lysis buffer. After incubating at room temperature for 5 min, the light absorbance was measured at 650 nm.
Statistical analysis. All data are expressed as the mean±SD. The results were analysed with a Student's t-test, and P<0.05 was regarded as statistically significant.
